Bankers say the US company failed to meet the terms of the pact as per agreed timeline.

A consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.

Besides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second rou...

“After the amendment, Section 74 of the insolvency code prescribes stringent punishment to resolution applicant if it fails to implement a ...

The move comes even as Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over ...

The drug maker was among the 28 companies that the RBI mandated banks to refer to bankruptcy court by December 2017.

Orchid Pharma was referred to the bankruptcy court by Lakshmi Vilas Bank after it failed to pay about Rs 3,500 crore to lenders.

Lanco Infratech, one of the first 12 stressed assets referred for insolvency resolution by the Reserve Bank of India in June last year, owe...

With a debt of about Rs 45,000 crore, Lanco Infratech is one of the 12 stressed accounts identified by the Reserve Bank of India for resolu...

The resolution professional who is in charge of the management of the Chennai-based company has set April 25 as the fresh date for submitti...

Lanco is an infrastructure group with interests in roads and power.

Lanco, holding company of several power and infrastructure projects, has debt of more than Rs 45,000 crore, taken from 29 financial credito...

The company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.

The collaboration will help UPL in providing farm services and precision farming solutions to farmers and several other value added service...